FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2613753586> ?p ?o ?g. }

• W2613753586 endingPage "3255" @default.
• W2613753586 startingPage "3255" @default.
• W2613753586 abstract "Abstract Background: Cytogenetic evaluation using fluorescence in situ hybridization (FISH) at the time of diagnosis is essential for initial risk stratification in multiple myeloma. Despite the absence of cytogenetic high-risk abnormalities a subset of patients does experience poor overall survival comparable high-risk disease (i.e. median overall survival less than three years after diagnosis). We aimed to identify demographic, clinical, and cytogenetic characteristics predicting poor three-year overall survival in patients with standard-risk cytogenetics. Methods: We studied 428 patients who were diagnosed with multiple myeloma between July 2004 and July 2014 at Mayo Clinic Rochester, underwent FISH evaluation within six months of diagnosis, and received treatment with novel agents (immunomodulator, proteasome-inhibitor, or a combination thereof). Patients with high- and intermediate-risk cytogenetics as well as patients lost to follow-up within three years were excluded. High-risk cytogenetics were defined as del(17p), t(14;16), and t(14;20). Intermediate-risk cytogenetics were defined as t(4;14) and gain(1q). Bone marrow aspirates were evaluated for deletions, monosomies, trisomies, and tetrasomies using chromosome- or centromere-specific FISH probes. IGH rearrangements were evaluated using an IGH break-apart probe and evaluating up to five potential partners (FGFR3, CCND1, CCND3, MAF, and MAFB). A multivariable-adjusted logistic regression model was used to assess the associations between the parameters of interest and three-year overall survival. Discrimination and calibration of the model were evaluated using the c-statistic and the Hosmer-Lemeshow test, respectively. The odds ratios of the identified predictors were rounded up to the next integer and assigned as points in a scoring system. Receiver operating characteristic analysis was used to determine the optimal cut-point and associated test performance characteristics. P-values below 0.05 were considered statistically significant. Results: The median age at diagnosis was 65 years (31 - 95), 259 (61%) of the patients were male. The median overall survival was 7.4 years (6.1 - 8.6) for the entire cohort (n = 428), 10.5 years (8.3 - NR) for those who survived at least three years (n = 327, 76%), and 1.6 years (1.2 - 1.7) for those who did not survive three years after diagnosis (n = 101, 24%). The factors associated with poor three-year overall survival and the derived scoring system are summarized in Table 1. Conclusions: Patients with multiple myeloma and standard-risk cytogenetics are a heterogeneous group. One fourth of the patients are experiencing less than three years of overall survival after diagnosis. Stage, age, extent of bone marrow involvement, karyotype, and platelet count at the time of diagnosis were helpful in identifying patients at risk for poor three-year overall survival. These findings emphasize the importance of further risk stratification in this patient population and warrant external validation. Disclosures Dispenzieri: Takeda: Membership on an entity's Board of Directors or advisory committees, Research Funding; Jannsen: Research Funding; pfizer: Research Funding; Prothena: Membership on an entity's Board of Directors or advisory committees; GSK: Membership on an entity's Board of Directors or advisory committees; Celgene: Research Funding; Alnylam: Research Funding. Kapoor:Takeda: Research Funding; Amgen: Research Funding; Celgene: Research Funding. Kumar:AbbVie: Research Funding; BMS: Consultancy; Amgen: Consultancy, Research Funding; Takeda: Consultancy, Research Funding; Sanofi: Consultancy, Research Funding; Celgene: Consultancy, Research Funding; Noxxon: Consultancy, Honoraria; Janssen: Research Funding; Skyline: Consultancy, Honoraria." @default.
• W2613753586 created "2017-05-19" @default.
• W2613753586 creator A5001453763 @default.
• W2613753586 creator A5002248011 @default.
• W2613753586 creator A5012403700 @default.
• W2613753586 creator A5016853434 @default.
• W2613753586 creator A5023193953 @default.
• W2613753586 creator A5026574827 @default.
• W2613753586 creator A5029802364 @default.
• W2613753586 creator A5033220547 @default.
• W2613753586 creator A5035289098 @default.
• W2613753586 creator A5036150860 @default.
• W2613753586 creator A5038404580 @default.
• W2613753586 creator A5042275995 @default.
• W2613753586 creator A5051470930 @default.
• W2613753586 creator A5052346975 @default.
• W2613753586 creator A5068637846 @default.
• W2613753586 creator A5072502164 @default.
• W2613753586 creator A5076611748 @default.
• W2613753586 creator A5079007941 @default.
• W2613753586 date "2016-12-02" @default.
• W2613753586 modified "2023-09-30" @default.
• W2613753586 title "Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents" @default.
• W2613753586 doi "https://doi.org/10.1182/blood.v128.22.3255.3255" @default.
• W2613753586 hasPublicationYear "2016" @default.
• W2613753586 type Work @default.
• W2613753586 sameAs 2613753586 @default.
• W2613753586 citedByCount "0" @default.
• W2613753586 crossrefType "journal-article" @default.
• W2613753586 hasAuthorship W2613753586A5001453763 @default.
• W2613753586 hasAuthorship W2613753586A5002248011 @default.
• W2613753586 hasAuthorship W2613753586A5012403700 @default.
• W2613753586 hasAuthorship W2613753586A5016853434 @default.
• W2613753586 hasAuthorship W2613753586A5023193953 @default.
• W2613753586 hasAuthorship W2613753586A5026574827 @default.
• W2613753586 hasAuthorship W2613753586A5029802364 @default.
• W2613753586 hasAuthorship W2613753586A5033220547 @default.
• W2613753586 hasAuthorship W2613753586A5035289098 @default.
• W2613753586 hasAuthorship W2613753586A5036150860 @default.
• W2613753586 hasAuthorship W2613753586A5038404580 @default.
• W2613753586 hasAuthorship W2613753586A5042275995 @default.
• W2613753586 hasAuthorship W2613753586A5051470930 @default.
• W2613753586 hasAuthorship W2613753586A5052346975 @default.
• W2613753586 hasAuthorship W2613753586A5068637846 @default.
• W2613753586 hasAuthorship W2613753586A5072502164 @default.
• W2613753586 hasAuthorship W2613753586A5076611748 @default.
• W2613753586 hasAuthorship W2613753586A5079007941 @default.
• W2613753586 hasConcept C104317684 @default.
• W2613753586 hasConcept C126322002 @default.
• W2613753586 hasConcept C143998085 @default.
• W2613753586 hasConcept C174475383 @default.
• W2613753586 hasConcept C2776364478 @default.
• W2613753586 hasConcept C2777542201 @default.
• W2613753586 hasConcept C2779142324 @default.
• W2613753586 hasConcept C2780189214 @default.
• W2613753586 hasConcept C30481170 @default.
• W2613753586 hasConcept C53226629 @default.
• W2613753586 hasConcept C54355233 @default.
• W2613753586 hasConcept C71924100 @default.
• W2613753586 hasConcept C86803240 @default.
• W2613753586 hasConceptScore W2613753586C104317684 @default.
• W2613753586 hasConceptScore W2613753586C126322002 @default.
• W2613753586 hasConceptScore W2613753586C143998085 @default.
• W2613753586 hasConceptScore W2613753586C174475383 @default.
• W2613753586 hasConceptScore W2613753586C2776364478 @default.
• W2613753586 hasConceptScore W2613753586C2777542201 @default.
• W2613753586 hasConceptScore W2613753586C2779142324 @default.
• W2613753586 hasConceptScore W2613753586C2780189214 @default.
• W2613753586 hasConceptScore W2613753586C30481170 @default.
• W2613753586 hasConceptScore W2613753586C53226629 @default.
• W2613753586 hasConceptScore W2613753586C54355233 @default.
• W2613753586 hasConceptScore W2613753586C71924100 @default.
• W2613753586 hasConceptScore W2613753586C86803240 @default.
• W2613753586 hasIssue "22" @default.
• W2613753586 hasLocation W26137535861 @default.
• W2613753586 hasOpenAccess W2613753586 @default.
• W2613753586 hasPrimaryLocation W26137535861 @default.
• W2613753586 hasRelatedWork W1531879063 @default.
• W2613753586 hasRelatedWork W1751726848 @default.
• W2613753586 hasRelatedWork W1991188105 @default.
• W2613753586 hasRelatedWork W1999463022 @default.
• W2613753586 hasRelatedWork W2038099628 @default.
• W2613753586 hasRelatedWork W2073549961 @default.
• W2613753586 hasRelatedWork W2125465115 @default.
• W2613753586 hasRelatedWork W2153192012 @default.
• W2613753586 hasRelatedWork W2163982699 @default.
• W2613753586 hasRelatedWork W2987326701 @default.
• W2613753586 hasVolume "128" @default.
• W2613753586 isParatext "false" @default.
• W2613753586 isRetracted "false" @default.
• W2613753586 magId "2613753586" @default.
• W2613753586 workType "article" @default.